Access cutting-edge organ transplant treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access organ transplant specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related organ transplant treatment provided free
Influenza virus is a significant pathogen in pediatric solid organ transplant (SOT) recipients. However, these individuals respond poorly to standard-dose (SD) inactivated influenza vaccine (IIV). Recent studies have investigated two strategies to overcome poor immune responses in SOT recipients: (1) administration of high-dose (HD)-IIV compared to SD-IIV and (2) two doses of SD-IIV compared to one dose of SD-IIV in the same influenza season. One study compared HD-IIV vs. SD-IIV in adult SOT rec
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this organ transplant clinical trial in Kansas City, MO
If you're searching for organ transplant treatment options in Kansas City, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced organ transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.